Microfluidics Market to Reach USD 46.13 Billion by 2031, Driven by Point-of-Care Diagnostics and AI-Enabled Lab-on-Chip Systems

November 16 19:47 2026
Microfluidics Market to Reach USD 46.13 Billion by 2031, Driven by Point-of-Care Diagnostics and AI-Enabled Lab-on-Chip Systems

Hyderabad, India – November 16, 2026 –

Microfluidics Market Overview

According to Mordor Intelligence, the microfluidics market size is estimated at USD 24.15 billion in 2025 and is projected to increase from USD 26.90 billion in 2026 to USD 46.13 billion by 2031, registering a CAGR of 11.39% during the forecast period. The market is gaining momentum as healthcare providers, pharmaceutical companies, and research institutions increasingly adopt technologies that process small fluid volumes with greater precision and efficiency.

North America held the largest regional share of the microfluidics market in 2025, supported by established diagnostic infrastructure, reimbursement frameworks, and pharmaceutical research activity. Asia-Pacific is expected to register the fastest growth during the forecast period, driven by investments in diagnostic infrastructure and medical-device development across countries such as China, India, and Japan.

Report Overview: https://www.mordorintelligence.com/industry-reports/microfluidics-market?utm_source=abnewswire

 

Microfluidics Market Trends

Increasing Demand for Point-of-Care Testing

The growing preference for rapid diagnostic testing is a key factor supporting microfluidics market growth. Healthcare providers increasingly require diagnostic platforms that deliver timely results and support treatment decisions closer to the point of care. Microfluidic cartridges can integrate sample preparation, amplification, and detection into compact systems, reducing the need for multiple laboratory processes.

These capabilities are particularly relevant in emergency departments, urgent-care facilities, and settings where access to specialized laboratory personnel is limited. Manufacturers are also expanding test menus to cover cardiac, metabolic, and respiratory conditions. As healthcare systems place greater emphasis on faster diagnosis and efficient patient management, point-of-care applications are expected to remain an important area of demand.

Growing Applications in Pharmaceutical and Biotechnology Research

Microfluidics is gaining importance in pharmaceutical and biotechnology research as companies seek more efficient ways to conduct drug discovery and biological analysis. Droplet-based systems allow researchers to examine individual cells and perform high-throughput screening while reducing sample and reagent requirements.

The technology also supports proteomics, genomics, and cell-based assays, helping research teams study complex biological processes. Pharmaceutical companies are increasingly exploring microfluidic platforms for applications such as single-cell profiling and cell-therapy development. These uses are expanding the role of microfluidics beyond diagnostic testing and creating additional opportunities across the research industry.

Adoption of AI-Enabled Lab-on-Chip Systems

Artificial intelligence is supporting the development of more advanced lab-on-chip platforms. AI-enabled systems can analyze images, monitor fluid movement, and interpret diagnostic signals, helping improve the consistency of microfluidic workflows. Integrating analytical capabilities into compact devices also supports decentralized molecular diagnostics.

These systems can be particularly useful in locations where access to specialized laboratory infrastructure or reliable internet connectivity is limited. As manufacturers combine microfluidic hardware with software-based analysis, integrated platforms are becoming increasingly relevant to healthcare providers and diagnostic laboratories.

Expansion of Organ-on-Chip Technologies

Organ-on-chip platforms are attracting attention in pharmaceutical research as alternatives for studying biological responses and evaluating drug candidates. These systems recreate selected features of human tissue and organ functions, allowing researchers to examine cellular interactions under controlled conditions.

The growing interest in approaches that reduce dependence on animal testing is supporting research into organ-on-chip technologies. Their applications in toxicity assessment, disease modelling, and drug development are creating new opportunities for microfluidic technology providers. Continued development of these platforms is expected to broaden the technology’s role in preclinical research.

Microfluidics Market Segmentation

The microfluidics market is segmented based on product type, application, material, technology, end user, and geography.

  • By Product Type

  • Microfluidic-based Devices

  • Microfluidic Components

  • Microfluidic Chips

  • Micro-pumps

  • Microneedles

  • Other Components

  • By Application

  • Drug Delivery

  • Point-of-Care Diagnostics

  • Pharmaceutical and Biotechnology Research

  • High-throughput Screening

  • Proteomics

  • Genomics

  • Cell-based Assay

  • Capillary Electrophoresis

  • Other Pharmaceutical and Biotechnology Research

  • Clinical Diagnostics

  • Other Applications

  • By Material

  • Polymer

  • Silicone

  • Glass

  • Paper and Other Porous Substrates

  • By Technology

  • Continuous-flow Microfluidics

  • Digital/Droplet Microfluidics

  • Organ-on-Chip and Tissue-chip

  • Acoustofluidics and Electrowetting

  • Centrifugal and Paper-based Microfluidics

  • By End User

  • Pharmaceutical and Biotechnology Companies

  • Diagnostic Laboratories

  • Academic and Research Institutes

  • Hospitals and Clinics

  • Contract Research and Manufacturing Organisations

  • By Geography

  • North America

  • United States

  • Canada

  • Mexico

  • Europe

  • Germany

  • United Kingdom

  • France

  • Italy

  • Spain

  • Rest of Europe

  • Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Rest of Asia-Pacific

  • Middle East and Africa

  • GCC

  • South Africa

  • Rest of Middle East and Africa

  • South America

  • Brazil

  • Argentina

  • Rest of South America

For more insights on the Japanese market report, please visit the Mordor Intelligence page: https://www.mordorintelligence.com/ja/industry-reports/microfluidics-market?utm_source=abnewswire

 

Microfluidics Market Competitive Landscape

The microfluidics market is moderately fragmented, with established life science and diagnostic technology companies competing alongside specialized microfluidic platform developers. Companies are focusing on expanding their product portfolios, improving instrument capabilities, and developing integrated solutions that combine chips, reagents, analytical tools, and software.

Strategic acquisitions and partnerships are also influencing the competitive environment. Companies are seeking to strengthen their capabilities in digital microfluidics, proteomics, single-cell analysis, and diagnostic workflow automation. At the same time, specialized developers are advancing organ-on-chip systems and application-specific platforms for pharmaceutical research.

The competitive landscape is expected to favor companies that can provide reliable systems while addressing workflow integration, manufacturing scalability, and regulatory requirements across different markets.

Key Players in the Microfluidics Market

  • Bio-Rad Laboratories Inc.

  • Illumina Inc.

  • PerkinElmer, Inc.

  • Standard BioTools (Fluidigm)

  • Agilent Technologies

  • Thermo Fisher Scientific

  • Becton Dickinson & Co.

  • Emulate

  • Dolomite Microfluidics

  • Fluigent

Conclusion

The microfluidics market is expected to maintain its growth trajectory as demand increases for rapid diagnostics, decentralized testing, and advanced pharmaceutical research tools. The adoption of AI-enabled lab-on-chip systems, single-cell analysis, and organ-on-chip technologies is broadening the range of applications across healthcare and life sciences.

While high equipment costs, workflow integration requirements, and regulatory complexity may affect adoption, continued investment in diagnostic infrastructure and microfluidic manufacturing is expected to support market expansion. North America is positioned to retain its leading regional position, while Asia-Pacific is expected to offer significant growth opportunities during the forecast period.

About Mordor Intelligence

Mordor Intelligence is a global market intelligence firm, founded in 2014, helping businesses make informed decisions through data-driven insights, industry expertise, and advanced analytics. With 550+ domain experts and on-ground specialists across 150+ countries, the company delivers comprehensive intelligence across aerospace & defense, agriculture, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, and logistics.

Its offerings include syndicated industry reports and subscription platforms such as Synapse. Mordor Intelligence is ISO 9001:2015 and ISO/IEC 27001:2022 certified, a member of ESOMAR and the Market Research Society of India, and a four-time Great Place to Work® honoree. Learn more at mordorintelligence.com.

Media Contact
Company Name: Mordor Intelligence Private Limited
Contact Person: Jignesh Thakkar
Email: Send Email
Phone: +1 617-765-2493
Address:11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli
City: Hyderabad
State: Telangana 500008
Country: India
Website: https://www.mordorintelligence.com/